The Association of Clinical Research Organizations (ACRO) and the FDA have announced a new initiative to modernize the clinical trial process with the formation of a collaborative group to support the development of data collection standards for regulated biomedical/clinical research. The collaborative is part of the FDA’s Human Subject Protection/Biomedical Research (HSP/BiMo) effort, a component of the agency’s Critical Path Initiative. The Clinical Data Interchange Standards ...